4//SEC Filing
Ji Henry 4
Accession 0001209191-22-049065
CIK 0000850261other
Filed
Sep 6, 8:00 PM ET
Accepted
Sep 7, 6:22 PM ET
Size
11.3 KB
Accession
0001209191-22-049065
Insider Transaction Report
Form 4
Ji Henry
DirectorChief Sci. Officer & Secretary10% Owner
Transactions
- Purchase
Common Stock
2022-09-07$2.02/sh+88,888$179,349→ 4,765,805 total - Purchase
Call Option (right to buy)
2022-09-07$40.66/sh+759$30,861→ 759 total(indirect: By BioVintage, Inc.)Exercise: $12.00From: 2022-09-07Exp: 2024-01-19→ Common Stock (75,900 underlying) - Purchase
Call Option (right to buy)
2022-09-07$41.66/sh+129$5,374→ 129 total(indirect: By BioVintage, Inc.)Exercise: $12.00From: 2022-09-07Exp: 2024-01-19→ Common Stock (12,900 underlying)
Holdings
- 2,271,693(indirect: See Footnote)
Common Stock
- 40,000(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.01 to $2.02, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each separate price.
- [F2]Shares are held in family trusts of which the Reporting Person is a co-trustee with his spouse.
Documents
Issuer
Sorrento Therapeutics, Inc.
CIK 0000850261
Entity typeother
Related Parties
1- filerCIK 0001470981
Filing Metadata
- Form type
- 4
- Filed
- Sep 6, 8:00 PM ET
- Accepted
- Sep 7, 6:22 PM ET
- Size
- 11.3 KB